共 115 条
[1]
de Bont JM(2007)Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis J Neuropathol Exp Neurol 66 505-516
[2]
den Boer ML(2017)Current therapy and the evolving molecular landscape of paediatric ependymoma Eur J Cancer 70 34-41
[3]
Kros JM(2011)Molecular genetics of ependymoma Chin J Cancer 30 669-681
[4]
Passier MM(2018)Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling Nature 553 101-105
[5]
Reddingius RE(2004)The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients Cancer 100 1230-1237
[6]
Smitt PA(2008)The prognostic value of histological grading of posterior fossa ependymomas in children: a Children’s Oncology Group study and a review of prognostic factors Mod Pathol 21 165-177
[7]
Khatua S(2011)Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts J Negat Results Biomed. 10 7-157
[8]
Ramaswamy V(2011)Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma Cancer Cell 20 143-197
[9]
Bouffet E(2013)Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression J Neurooncol 112 191-6460
[10]
Yao Y(2013)PI3K pathway activation provides a novel therapeutic target for pediatric ependymoma and is an independent marker of progression-free survival Clin Cancer Res 19 6450-297